Pilot Study of the Safety and Efficacy of Anakinra in Pulmonary Arterial Hypertension

Completed · Phase 1

Conditions studied: Pulmonary Arterial Hypertension

In brief

Pulmonary arterial hypertension (PAH) can result in right ventricular failure and death. Anakinra has been used in patients with left sided heart failure, and the present study looks to determine if anakinra is safe and effective in patients with PAH. To accomplish this goal, we plan to evaluate for exercise improvement (as assessed by cardiopulmonary exercise testing) in 10 patients with PAH on anakinra.

Key facts

Study ID
NCT03057028
Run by
Virginia Commonwealth University
People needed
7
Starts
2016-04-01
Expected to finish
2018-06-07
Last updated by the study team
2019-04-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.